|1.||Esteban, Mariano: 2 articles (01/2015 - 09/2012)|
|2.||Earl, Patricia: 2 articles (10/2012 - 09/2004)|
|3.||Moss, Bernard: 2 articles (10/2012 - 09/2004)|
|4.||Hallahan, Claire W: 2 articles (03/2007 - 10/2003)|
|5.||Johnson, Alison J: 2 articles (03/2007 - 10/2003)|
|6.||Tilton, John C: 2 articles (03/2007 - 10/2003)|
|7.||Connors, Mark: 2 articles (03/2007 - 10/2003)|
|8.||Davey, Richard T: 2 articles (03/2007 - 10/2003)|
|9.||Kwak, Larry W: 2 articles (10/2004 - 08/2002)|
|10.||Pastor, Lucia: 1 article (04/2015)|
|2.||Adenoviridae Infections (Adenovirus Infections)
|3.||HIV Infections (HIV Infection)
10/01/1989 - "Results strongly indicate that nondenaturing live-cell immunofluorescence is much more sensitive for detection of HIV-associated antigens and may be useful in the diagnosis of HIV infection as well as in the study of pathogenesis."
04/01/2015 - "Acute human immunodeficiency virus (HIV) infection (AHI) refers to the period between viral transmission and development of an adaptive immune response to HIV antigens (seroconversion) usually lasting 6-8 weeks. "
07/01/2011 - "Human immunodeficiency virus (HIV) antigens from transmitted strains of HIV would prove crucial in vaccine designing for prevention of HIV infection. "
01/01/2005 - "New screening enzyme immunoassays, which permit the simultaneous detection of HIV antigens reduce the diagnostic window period between the time of immunodeficiency virus (HIV) infection and seroconversion. "
07/01/2004 - "In the chronic stage of HIV infection T cell proliferative responses to HIV antigens are rare, mostly of low level, and the influence of responses on antiretroviral therapy is not known. "
|4.||Acquired Immunodeficiency Syndrome (AIDS)
10/01/1985 - "This donor had an OKT4:OKT8 ratio of 0.4 and was seropositive for HTLV-III antigens; HTLV-III virus was identified in his PBL; and he developed AIDS during the course of this study. "
12/01/2008 - "In this article, we explore the potential of transplastomic plants to produce human immunodeficiency virus (HIV) antigens as potential components of an acquired immunodeficiency syndrome (AIDS) vaccine. "
12/01/2001 - "The specific targeting of responding CD8 lymphocytes may provide a functional explanation for the previously observed impairment of cytotoxic T-lymphocyte (CTL) function disproportionate to their numerical decline in AIDS and for the deletion of specific clones of CTLs responding to HIV antigens."
12/01/1991 - "[Occurrence of HIV antigens in patients with acquired immunodeficiency syndrome]."
05/01/1991 - "Expression of major histocompatibility complex and HIV antigens within the brains of AIDS patients."
02/15/2001 - "The frequency of CD8(+) CTL response to HIV antigens was similar between vaccinia-naive and vaccinia-immune persons. "
10/01/2012 - "In a preclinical study we compared the ability of recombinant modified vaccinia Ankara encoding HIV antigens (MVA-CMDR), and/or recombinant gp140C (rgp140C), to boost responses induced by a multigene/multisubtype HIV DNA vaccine delivered by electroporation (EP). "
09/09/2004 - "Following boosting with a recombinant modified vaccinia Ankara (rMVA) producing full-length SIV and HIV antigens, it appeared that priming with hybrid DNA had increased virus-specific T-cell responses in terms of both the number of virus-specific IFN-gamma-secreting T-cells and virus-specific lymphoproliferation. "
01/01/2015 - "Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen."
|2.||DNA (Deoxyribonucleic Acid)
|3.||Immunoglobulin A (IgA)
|5.||beta 2-Microglobulin (beta 2 Microglobulin)
|8.||Immunoglobulin G (IgG)
|10.||Proteins (Proteins, Gene)